Promoter methylation status and protein expression of p14ARF gene in squamous cell carcinoma and adenocarcinoma of the lung

Chinese Journal of Lung Cancer

Volumn 9, Issue 1, 2006, Pages 40-44

  Tian, Kaihua ^a   Lin, Lesheng ^b   Jia, Zhaotong ^b   Guo, Xiaojing ^b   Zhang, Lin ^b  

^a QINGDAO UNIVERSITY   (China)

^b NONE

Author keywords

Lung neoplasms; Methylation; p14ARF; Tumor suppressor gene

Indexed keywords

PROTEIN P14ARF;

ADENOCARCINOMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; METHYLATION; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION MAPPING; SQUAMOUS CELL CARCINOMA;

EID: 33645065155     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Quelle DE, Zindy F, Ashmun RA, et al. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell, 1995, 83(6): 993-1000.
2. Zhang Y, Xiong Y, Yarbrough WG. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell, 1998, 92(6): 725-734.
3. Robertson KD, Jones PA. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol Cell Biol, 1998, 18(11):6457-6473.
4. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. 2nd ed. New York: Cold Spring Harbor Laboratory Press, 1989. 463-467.
5. Weihrauch M, Markwarth A, Lehnert G, et al. Abnormalities of the ARF-p53 pathway in primary angiosarcomas of the liver. Hum Pathol, 2002, 33(9):884-892.
6. INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res, 1999, 5(10):2704-2713.
7. Paz MF, Avila S, Fraga MF, et al. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res, 2002, 62 (15):4519-4524.
8. Esteller M, Tortola S, Toyota M, et al. Hypermethylation-associated inactivation of p14 (ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res, 2000, 60(1): 129-133.
9. Kim DH, Kim JS, Ji YI, et al. Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer. Cancer Res, 2003, 63(13):3743-3746.
10. ARF alterations in nonsmall cell lung carcinoma. Cancer Genet Cytogenet, 2003, 141(1):5-13.
11. Zochbauer-Muller S, Fong KM, Virmani AK, et al. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res, 2001, 61(1):249-255.
12. Gonzalgo ML, Hayashida T, Bender CM, et al. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. Cancer Res, 1998, 58(6):1245-1252.
13. Belinsky SA, Nikula KJ, Palmisano WA, et al. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci U S A, 1998, 95 (20):11891-11896.